vimarsana.com

Latest Breaking News On - Konstantinos leventakos - Page 1 : vimarsana.com

Novel Frontline Combinations Influence Later-Line Treatment Strategies in SCLC

While progress in outcomes has been greater in non–small cell lung cancer, recent advances, including molecularly targeted therapies against EGFR and ALK, checkpoint inhibitors that boost immune response, improved staging, and video-assisted surgery have all contributed to progress in treatment of all types of lung cancer, including in SCLC.

Dr Konstantinos Leventakos Highlights the Challenge of Treatment Metastatic SCLC

Small cell lung cancer (SCLC) needs to be treated quickly once diagnosed, said Konstantinos Leventakos, MD, PhD, assistant professor of oncology and medicine, Mayo Clinic, Rochester, Minnesota.

Dr Konstantinos Leventakos: Identification of Biomarkers in SCLC Is Crucial

While some types of lung cancer have targeted therapies, there remains a need for identification of biomarkers to predict treatment response in small cell lung cancer (SCLC).

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.